Dr Peter Hamley

About

Dr Peter Hamley is an Advisory Board Member at UKI2S with a career in the biotech industry. He began at AstraZeneca after completing a PhD at Cambridge University, postdoctoral studies at the University of Pennsylvania, and an MBA from the University of Bath, and later spent more than a decade at Sanofi in drug discovery leadership and development roles. He currently serves as CSO of Samsara Therapeutics, which works on autophagy therapeutics, and has authored more than 60 patents, papers and book chapters.